Showing results (381-390 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|July 5, 2022
Structural variants shape driver combinations and outcomes in pediatric high-grade gliomaFrank P B Dubois, Ofer Shapira, Noah F Greenwald, et al.Nature Cancer|June 30, 2022
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapyAdrián Álvarez-Varela, Laura Novellasdemunt, Francisco M Barriga, et al.Nature Cancer|February 1, 2021
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancerC Allison Stewart, Carl M Gay, Yuanxin Xi, et al.Nature Cancer|January 22, 2021
Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment is dependent on Stearoyl CoA desaturaseAngela Maria Savino, Sara Isabel Fernandes, Orianne Olivares, et al.Nature Cancer|March 1, 2021
Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in GlioblastomaMartina Castellan, Alberto Guarnieri, Atsushi Fujimura, et al.Nature Cancer|February 5, 2022
Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesisQi Cui, Kailin Yin, Xiaoting Zhang, et al.Nature Cancer|February 5, 2022
Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohortLaurence Albiges, Stéphanie Foulon, Arnaud Bayle, et al.Nature Cancer|February 5, 2022
Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncologyBrendan Reardon, Nathanael D Moore, Nicholas S Moore, et al.Nature Cancer|February 5, 2022
RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunityZhuo Zhang, Lin Luo, Chuan Xing, et al.Nature Cancer|February 5, 2022
Super enhancers define regulatory subtypes and cell identity in neuroblastomaMoritz Gartlgruber, Ashwini Kumar Sharma, Andrés Quintero, et al.Pageof 65